Literature DB >> 28691768

Microbiome, inflammation, epigenetic alterations, and mental diseases.

Reza Alam1, Hamid M Abdolmaleky1, Jin-Rong Zhou1.   

Abstract

Major mental diseases such as autism, bipolar disorder, schizophrenia, and major depressive disorder are debilitating illnesses with complex etiologies. Recent findings show that the onset and development of these illnesses cannot be well described by the one-gene; one-disease approach. Instead, their clinical presentation is thought to result from the regulative interplay of a large number of genes. Even though the involvement of many genes are likely, up regulating and activation or down regulation and silencing of these genes by the environmental factors play a crucial role in contributing to their pathogenesis. Much of this interplay may be moderated by epigenetic changes. Similar to genetic mutations, epigenetic modifications such as DNA methylation, histone modifications, and RNA interference can influence gene expression and therefore may cause behavioral and neuronal changes observed in mental disorders. Environmental factors such as diet, gut microbiota, and infections have significant role in these epigenetic modifications. Studies show that bioactive nutrients and gut microbiota can alter either DNA methylation and histone signatures through a variety of mechanisms. Indeed, microbes within the human gut may play a significant role in the regulation of various elements of "gut-brain axis," via their influence on inflammatory cytokines and production of antimicrobial peptides that affect the epigenome through their involvement in generating short chain fatty acids, vitamin synthesis, and nutrient absorption. In addition, they may participate in-gut production of many common neurotransmitters. In this review we will consider the potential interactions of diet, gastrointestinal microbiome, inflammation, and epigenetic alterations in psychiatric disorders.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  epigenetics; inflammation; microbiome; nutrition; psychiatric disorders

Mesh:

Year:  2017        PMID: 28691768      PMCID: PMC9586840          DOI: 10.1002/ajmg.b.32567

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.358


  94 in total

Review 1.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 2.  Gut-brain axis in 2016: Brain-gut-microbiota axis - mood, metabolism and behaviour.

Authors:  Timothy G Dinan; John F Cryan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

3.  Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 131I-sodium tracers in the rat.

Authors:  H S Sharma; J Westman; J C Navarro; P K Dey; F Nyberg
Journal:  Behav Brain Res       Date:  1995-12-14       Impact factor: 3.332

Review 4.  Inflammation and clinical response to treatment in depression: A meta-analysis.

Authors:  R Strawbridge; D Arnone; A Danese; A Papadopoulos; A Herane Vives; A J Cleare
Journal:  Eur Neuropsychopharmacol       Date:  2015-06-20       Impact factor: 4.600

5.  TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors.

Authors:  T Andrews; P Zhang; N R Bhat
Journal:  J Neurosci Res       Date:  1998-12-01       Impact factor: 4.164

6.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.

Authors:  M Maes; H Y Meltzer; E Bosmans; R Bergmans; E Vandoolaeghe; R Ranjan; R Desnyder
Journal:  J Affect Disord       Date:  1995-08-18       Impact factor: 4.839

7.  The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).

Authors:  C L Raison; A H Miller
Journal:  Mol Psychiatry       Date:  2012-01-31       Impact factor: 15.992

Review 8.  Epigenetic reprogramming of host genes in viral and microbial pathogenesis.

Authors:  Konstantinos Paschos; Martin J Allday
Journal:  Trends Microbiol       Date:  2010-08-18       Impact factor: 17.079

9.  Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer's Disease.

Authors:  Ingrid H Philippens; Paul R Ormel; Guus Baarends; Maja Johansson; Ed J Remarque; Magnus Doverskog
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis.

Authors:  Hengameh C Mirsepasi-Lauridsen; Sofie Ingdam Halkjaer; Esben Munk Mortensen; Magnus C Lydolph; Inge Nordgaard-Lassen; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

View more
  55 in total

Review 1.  Evolutionary concepts in the functional biotics arena: a mini-review.

Authors:  Basavaprabhu H Nataraj; Sonu K Shivanna; Prabha Rao; Ravinder Nagpal; Pradip V Behare
Journal:  Food Sci Biotechnol       Date:  2020-09-16       Impact factor: 2.391

2.  Culture as an ingredient of personalized medicine.

Authors:  Kimberly Matheson; Amy Bombay; Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2018-01       Impact factor: 6.186

Review 3.  Optimizing the chances of success in the search for epigenetic biomarkers: Embracing genetic variation.

Authors:  Robert Philibert; Stephen J Glatt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-07-11       Impact factor: 3.568

4.  Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.

Authors:  Hamid M Abdolmaleky; Adam C Gower; Chen-Khuan Wong; Jiayi W Cox; Xiaoling Zhang; Arunthathi Thiagalingam; Rahim Shafa; Vadivelu Sivaraman; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-11-23       Impact factor: 3.568

Review 5.  Targeting the immune system in the treatment of bipolar disorder.

Authors:  Joshua D Rosenblat
Journal:  Psychopharmacology (Berl)       Date:  2019-02-13       Impact factor: 4.530

6.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

7.  Inhibition of EZH2 (Enhancer of Zeste Homolog 2) Attenuates Neuroinflammation via H3k27me3/SOCS3/TRAF6/NF-κB (Trimethylation of Histone 3 Lysine 27/Suppressor of Cytokine Signaling 3/Tumor Necrosis Factor Receptor Family 6/Nuclear Factor-κB) in a Rat Model of Subarachnoid Hemorrhage.

Authors:  Yujie Luo; Yuanjian Fang; Ruiqing Kang; Cameron Lenahan; Marcin Gamdzyk; Zeyu Zhang; Takeshi Okada; Jiping Tang; Sheng Chen; John H Zhang
Journal:  Stroke       Date:  2020-09-16       Impact factor: 7.914

Review 8.  Metabolomics Biomarkers for Precision Psychiatry.

Authors:  Pei-An Betty Shih
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis.

Authors:  He-Ming Huang; Shi-Jie Fan; Xiao-Ru Zhou; Yan-Jun Liu; Xiao Li; Li-Ping Liao; Jing Huang; Cui-Cui Shi; Liang Yu; Rong Fu; Jian-Gao Fan; Yuan-Yuan Zhang; Cheng Luo; Guang-Ming Li
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

Review 10.  Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder.

Authors:  Dinyadarshini Johnson; Sivakumar Thurairajasingam; Vengadesh Letchumanan; Kok-Gan Chan; Learn-Han Lee
Journal:  Nutrients       Date:  2021-05-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.